Analytical Data
-
Gene name
SIRPD
- Application
-
Alternative Names
Protein tyrosine phosphatase non-receptor type substrate 1-like 2
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H106
-
Expression Region
30-197aa
-
Molecular Weight
34.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The SIRPD (Signal Regulatory Protein Delta) is a member of the signal regulatory protein family, which plays a crucial role in the regulation of immune responses. This protein is known for its involvement in modulating T cell activation and inhibiting dendritic cell maturation, thereby influencing the overall immune response. Given its critical functions, SIRPD has garnered interest in various research fields, particularly in immunology and cancer therapy. The recombinant expression of SIRPD allows for detailed studies of its structure-function relationships and interactions with other immune cells. Additionally, the manipulation of SIRPD activity has therapeutic potential in enhancing immune responses against tumors or in suppressing autoimmune diseases. The generation of SIRPD recombinant proteins facilitates the development of assays and models to explore its signaling pathways and biological effects. Furthermore, understanding SIRPD's mechanisms could lead to novel interventions in immune modulation, making it a valuable target for future research aimed at improving vaccine efficacy and treating inflammatory conditions.
